GOSS - Gossamer Bio promotes Caryn Peterson to executive vice president regulatory affairs

Clinical-stage biopharmaceutical company Gossamer Bio (GOSS) announces the promotion of Caryn Peterson to Executive Vice President, Regulatory Affairs.Peterson previously served as Senior Vice President, Regulatory & Quality after joining Gossamer in 2018.He will continue to lead the company's Regulatory and Quality functions, tasked with strategizing and implementing global regulatory strategies for all clinical and pre-clinical programs, in addition to co-leading Gossamer's CMC efforts.Shares up more than 3% premarket.

For further details see:

Gossamer Bio promotes Caryn Peterson to executive vice president, regulatory affairs